Explaining the Bias in the 23S rRNA Gene Mutations Associated with Clarithromycin Resistance in Clinical Isolates of Helicobacter pylori
- 1 October 1998
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 42 (10), 2749-2751
- https://doi.org/10.1128/aac.42.10.2749
Abstract
A single point mutation in the 23S rRNA gene of Helicobacter pylori is known to confer resistance to clarithromycin. Most prevalent among clarithromycin-resistant clinical H. pylori isolates are the mutations from A-2142 to G and A-2143 to G in the 23S rRNA gene. The bias in the 23S rRNA gene mutations conferring clarithromycin resistance may result from the higher MIC, stability of resistance, and growth rate found for the strains with the above-mentioned mutations.Keywords
This publication has 12 references indexed in Scilit:
- Cloning and sequence analysis of two copies of a 23S rRNA gene from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutationsAntimicrobial Agents and Chemotherapy, 1997
- Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group.Gut, 1997
- Mechanism of clarithromycin resistance in clinical isolates ofHelicobacter pyloriFEMS Microbiology Letters, 1996
- Clarithromycin resistance in Helicobacter pylori: prevalence in untreated dyspeptic patients and stability in vitroJournal of Antimicrobial Chemotherapy, 1996
- PCR-Based Site-Directed MutagenesisPublished by Springer Nature ,1995
- Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated diseaseAntimicrobial Agents and Chemotherapy, 1995
- The Treatment ofHelicobacter pyloriInfection in the Management of Peptic Ulcer DiseaseNew England Journal of Medicine, 1995
- Helicobacter pylori in Peptic Ulcer DiseaseJAMA, 1994
- Transformation of Helicobacter pylori by chromosomal metronidazole resistance and by a plasmid with a selectable chloramphenicol resistance markerJournal of General Microbiology, 1993
- PROSPECTIVE DOUBLE-BLIND TRIAL OF DUODENAL ULCER RELAPSE AFTER ERADICATION OF CAMPYLOBACTER PYLORIThe Lancet, 1988